United Therapeutics | UTHR - Pre Tax Profit

Stock Price
582.22
Daily Change
16.52 2.92%
Monthly
10.03%
Yearly
98.86%
Q2 Forecast
547.81

United Therapeutics reported $444M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amarin USD -852K 7.26M Dec/2025
Ardelyx USD -400K 467K Dec/2025
Baxter International USD 121M 12M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Insmed USD -326.93M 41.77M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
J&J USD 4.97B 2.53B Dec/2025
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
Moderna USD -187M 631M Sep/2025
Omeros USD -65.12M 21.27M Jun/2024
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
United Therapeutics USD 444M 6M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025